Answers are grounded in this paper and cite their sources.
reduced enhancer H3K27ac levels and chromatin accessibility, resulting in a reduction of POU2F3-dependent gene expression. On the basis of the molecular function of C11orf53, we renamed it as "POU Class 2 Homeobox Associating Factor 2" (POU2AF2). In summary, our study has identified a new coactivator of POU2F3 and sheds light on the therapeutic potential of targeting POU2AF2/POU2F3 heterodimer in human SCLC.
No takes yet. Share an insight, caveat, or question.
Szczepanski et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: